Zentalis Pharmaceuticals (ZNTL) Receivables - Other (2019 - 2023)
Zentalis Pharmaceuticals (ZNTL) posted quarterly Receivables - Other of $7.9 million for Q1 2023, up 236.8% year-over-year from $2.3 million in Q1 2022, and up 34.63% quarter-over-quarter from $5.9 million in Q4 2022.
Zentalis Pharmaceuticals (ZNTL) Receivables - Other (2019 - 2023) Analysis & Trends
Zentalis Pharmaceuticals' Receivables - Other history runs 5 years deep, the most recent figure standing at $7.9 million for Q1 2023.
- In Q1 2023, Receivables - Other rose 236.8% year-over-year to $7.9 million; the TTM figure through Mar 2023 stood at $7.9 million (up 236.8% YoY), while the FY2022 annual figure was $5.9 million, up 147.53% from the prior year.
- Receivables - Other for Q1 2023 stood at $7.9 million, up from $5.9 million in the prior quarter.
- The five-year high for Receivables - Other was $82.0 million in Q1 2020, with the low at $100000.0 in Q2 2020.
- The 5-year median for Receivables - Other is $2.4 million (2021), against an average of $9.5 million.
- The sharpest annual moves came in 2020 and 2022: Receivables - Other jumped 10150.0% in 2020, then slumped 92.43% in 2022.
- Zentalis Pharmaceuticals' Receivables - Other stood at $200000.0 in 2019, then surged by 155.5% to $511000.0 in 2020, then surged by 364.38% to $2.4 million in 2021, then jumped by 147.53% to $5.9 million in 2022, then jumped by 34.63% to $7.9 million in 2023.
- Business Quant data shows ZNTL's Receivables - Other at $7.9 million in Q1 2023, $5.9 million in Q4 2022, and $3.2 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zentalis Pharmaceuticals | 255.14 Mn | 255.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 7.91 Mn |
| Mar 31, 2023 | 7.91 Mn |
| Dec 31, 2022 | 5.87 Mn |
| Dec 31, 2022 | 5.87 Mn |
| Sep 30, 2022 | 3.23 Mn |
| Sep 30, 2022 | 3.23 Mn |
| Jun 30, 2022 | 2.98 Mn |
| Jun 30, 2022 | 2.98 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | 2.37 Mn |
| Dec 31, 2021 | 2.37 Mn |
| Sep 30, 2021 | 2.94 Mn |
| Sep 30, 2021 | 2.94 Mn |
| Mar 31, 2021 | 31.00 Mn |
| Mar 31, 2021 | 31.00 Mn |
| Sep 30, 2020 | 511,000.00 |
| Sep 30, 2020 | 511,000.00 |
| Jun 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 100,000.00 |